AffiliationAlimentary Pharmabiotic Centre, Department of Medicine, National University of, Ireland, Cork University Hospital, Wilton, Cork, Ireland. firstname.lastname@example.org
MeSHCost of Illness
Health Care Costs
Irritable Bowel Syndrome/economics/*epidemiology/therapy
Quality of Life
MetadataShow full item record
CitationDig Liver Dis. 2006 Oct;38(10):717-23. Epub 2006 Jun 27.
JournalDigestive and liver disease : official journal of the Italian Society of, Gastroenterology and the Italian Association for the Study of the Liver
AbstractIrritable bowel syndrome affects approximately 10-15% of the European population, although prevalence rates vary depending on the classification used and the country surveyed. This may be due to differences in patterns of medical care and diagnosis of the condition. Up to 70% of individuals with irritable bowel syndrome may not have been formally diagnosed. The disorder affects 1.5-3 times as many women as men and poses a significant economic burden in Europe, estimated at euro 700-euro 1600 per person per year. It also reduces quality of life and is associated with psychological distress, disturbed work and sleep, and sexual dysfunction. It is a chronic disorder, which affects many individuals for more than 10 years. Most patients are managed in primary care, although some are referred to gastroenterologists and other specialists. Patients with irritable bowel syndrome undergo more abdomino-pelvic surgery than the general population. We propose that a positive diagnosis of the condition may avoid the delay in diagnosis many patients experience. We conclude that, in Europe, there are significant unmet needs including lack of familiarity with irritable bowel syndrome, difficulties in diagnosis and lack of effective treatments for the multiple symptoms of the disorder. The development of pan-European guidelines for irritable bowel syndrome will benefit patients with this condition in Europe.
- Gender difference on the symptoms, health-seeking behaviour, social impact and sleep quality in irritable bowel syndrome: a Rome II-based survey in an apparent healthy adult Chinese population in Taiwan.
- Authors: Lu CL, Chang FY, Lang HC, Chen CY, Luo JC, Lee SD
- Issue date: 2005 Jun 15
- Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers.
- Authors: Faresjö A, Grodzinsky E, Foldevi M, Johansson S, Wallander MA
- Issue date: 2006 Mar 15
- [Irritable bowel syndrome: epidemiology/economic burden].
- Authors: Dapoigny M
- Issue date: 2009 Feb
- Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome.
- Authors: Williams RE, Black CL, Kim HY, Andrews EB, Mangel AW, Buda JJ, Cook SF
- Issue date: 2006 Jun 1
- Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome.
- Authors: Martin BC, Ganguly R, Pannicker S, Frech F, Barghout V
- Issue date: 2003